Recombinant Human Complement factor H protein (rFc Tag)
ED50
/
Species
Human
Purity
>90 %, SDS-PAGE
GeneID
3075
Accession
P08603-1
验证数据展示
Technical Specifications
Purity | >90 %, SDS-PAGE |
Endotoxin Level | <1.0 EU/μg protein, LAL method |
Biological Activity |
Not tested |
Source | HEK293-derived Human Complement factor H protein Ser860-Arg1231 (Accession# P08603-1) with a rabbit IgG Fc tag at the C-terminus. |
Predicted Molecular Mass | 71.0 kDa |
SDS-PAGE | 75-95 kDa, reducing (R) condition |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Complement factor H (CFH) is an abundant plasma glycoprotein that regulates the function of the alternative complement pathway in the fluid phase and on cellular surfaces (PMID: 2963625). Factor H binds to C3b, accelerates the decay of the alternative pathway C3-convertase (C3bBb), and acts as a cofactor for the factor I-mediated proteolytic inactivation of C3b (PMID: 15163532). It plays a critical role in the homeostasis of the complement system in plasma and in the protection of bystander host cells and tissues from damage by complement activation. Abnormalities in factor H have been associated with renal disease (PMID: 18190458).
References:
1.Ripoche, J. et al.(1988) Biochem J. 249(2):593-602. 2.Esparza-Gordillo, J. et al.(2004) Mol immunol. 41(4):355-67. 3.Pickering, MC. et al.(2008) Clin exp immunol. 151(2):210-30.